🌐 WorldLive
Accueil › 🇬🇧 Royaume-Uni › Santé

Affinia gains Health Canada approval for UPBEAT Phase I/II trial

📅 07/04/2026 08:24 📰 clinicaltrialsarena 👁️ 6 lectures 🌍 Royaume-Uni 📂 Santé
Affinia gains Health Canada approval for UPBEAT Phase I/II trial

Affinia Therapeutics has received approval from Health Canada for its CTA to begin the UPBEAT Phase I/II study of AFTX-201 for BAG3-DCM. The post Affinia gains Health Canada approval for UPBEAT Phase I/II trial appeared first on Clinical Trials Arena .